Does OMALIZUMAB Cause Injection site warmth? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Injection site warmth have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.1% of all adverse event reports for OMALIZUMAB.
81
Reports of Injection site warmth with OMALIZUMAB
0.1%
of all OMALIZUMAB reports
0
Deaths
37
Hospitalizations
How Dangerous Is Injection site warmth From OMALIZUMAB?
Of the 81 reports, 37 (45.7%) required hospitalization, and 2 (2.5%) were considered life-threatening.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
Which OMALIZUMAB Alternatives Have Lower Injection site warmth Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS